Cargando…

Estrogen receptor-positive primary squamous cell carcinoma of the breast

Pure primary squamous cell carcinoma of the breast (SCCB) represents around 0.1% of breast carcinomas. Diagnosis requires independence from adjacent skin without metastatic disease. SCCB is often large at presentation with nonspecific mammographic and ultrasound findings. It is typically hormone rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Pribish, Abby M., Saglam, Ozlen, Weinfurtner, R. Jared
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417723/
https://www.ncbi.nlm.nih.gov/pubmed/28491153
http://dx.doi.org/10.1016/j.radcr.2017.01.008
_version_ 1783233941846622208
author Pribish, Abby M.
Saglam, Ozlen
Weinfurtner, R. Jared
author_facet Pribish, Abby M.
Saglam, Ozlen
Weinfurtner, R. Jared
author_sort Pribish, Abby M.
collection PubMed
description Pure primary squamous cell carcinoma of the breast (SCCB) represents around 0.1% of breast carcinomas. Diagnosis requires independence from adjacent skin without metastatic disease. SCCB is often large at presentation with nonspecific mammographic and ultrasound findings. It is typically hormone receptor negative and aggressive. Mastectomy and adjuvant chemotherapy is the most common treatment, although treatment guidelines are not well established. We present a case of pure primary SCCB detected by high risk screening mammogram and treated with breast conserving surgery, chemotherapy, and radiation. We discuss clinical, radiologic, and pathologic findings.
format Online
Article
Text
id pubmed-5417723
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54177232017-05-10 Estrogen receptor-positive primary squamous cell carcinoma of the breast Pribish, Abby M. Saglam, Ozlen Weinfurtner, R. Jared Radiol Case Rep Case Report Pure primary squamous cell carcinoma of the breast (SCCB) represents around 0.1% of breast carcinomas. Diagnosis requires independence from adjacent skin without metastatic disease. SCCB is often large at presentation with nonspecific mammographic and ultrasound findings. It is typically hormone receptor negative and aggressive. Mastectomy and adjuvant chemotherapy is the most common treatment, although treatment guidelines are not well established. We present a case of pure primary SCCB detected by high risk screening mammogram and treated with breast conserving surgery, chemotherapy, and radiation. We discuss clinical, radiologic, and pathologic findings. Elsevier 2017-02-04 /pmc/articles/PMC5417723/ /pubmed/28491153 http://dx.doi.org/10.1016/j.radcr.2017.01.008 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Pribish, Abby M.
Saglam, Ozlen
Weinfurtner, R. Jared
Estrogen receptor-positive primary squamous cell carcinoma of the breast
title Estrogen receptor-positive primary squamous cell carcinoma of the breast
title_full Estrogen receptor-positive primary squamous cell carcinoma of the breast
title_fullStr Estrogen receptor-positive primary squamous cell carcinoma of the breast
title_full_unstemmed Estrogen receptor-positive primary squamous cell carcinoma of the breast
title_short Estrogen receptor-positive primary squamous cell carcinoma of the breast
title_sort estrogen receptor-positive primary squamous cell carcinoma of the breast
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417723/
https://www.ncbi.nlm.nih.gov/pubmed/28491153
http://dx.doi.org/10.1016/j.radcr.2017.01.008
work_keys_str_mv AT pribishabbym estrogenreceptorpositiveprimarysquamouscellcarcinomaofthebreast
AT saglamozlen estrogenreceptorpositiveprimarysquamouscellcarcinomaofthebreast
AT weinfurtnerrjared estrogenreceptorpositiveprimarysquamouscellcarcinomaofthebreast